What would you like help with?
Pick the area that fits. We will show you the options a licensed clinician can review, with the price before you pay.
About 10 minutes · a clinician can decline · no insurance, flat cash pricing
Pick the area that fits. We will show you the options a licensed clinician can review, with the price before you pay.
About 10 minutes · a clinician can decline · no insurance, flat cash pricing
Compounded GLP-1 preparations act on the gut-hormone receptors that signal fullness and slow gastric emptying. Which one suits you, and at what dose, is a clinical decision.
Choosing an option starts the intake for it. A clinician may prescribe something different, or decline.
Microdosing holds a lower weekly dose on purpose rather than stepping up on the standard schedule. People choose it for a gentler start or for sensitivity to side effects at higher doses. Whether it suits you is a clinical judgement, not a preference you can select.
Choosing an option starts the intake for it. A clinician may prescribe something different, or decline.
These act on cellular energy metabolism and on your own hormone signalling rather than replacing a hormone. Mechanisms are well characterised; clinical outcomes are less settled.
Choosing an option starts the intake for it. A clinician may prescribe something different, or decline.
PDE5 inhibitors keep blood flow easier to achieve and hold. They do not create arousal: stimulation is still required. Combination preparations add a centrally acting agent.
Choosing an option starts the intake for it. A clinician may prescribe something different, or decline.